Dear Investor,

What would you do if you had a money-printing machine that funded your biggest dreams?

Would you travel the world to far away countries?

Would you open a vineyard and create endless blends of award winning red wine?

What would you do if you had a blank check to explore your passions?

That seems like a pretty sweet gig.

So what if I told you there is a tiny NASDAQ biotech that has one of those machines...

And it's funding all of their R&D efforts in one of the most critical and important sectors to ever exist...

That's right. This tiny $3M biotech has a revenue generating subsidiary that pays for all of their research in helping find a treatment for Alzheimer's disease.

Not only does that de-risk this company from an investor standpoint...

But it could also offer a massive runway to discover a crucial treatment in the race to cure Alzheimer's.

Find out this profitable and potentially critical biotech now in this full report.

Notice: Please understand that by opting out from future emails from this advertiser, you are transferring or
authorizing the transfer of your email address to the advertiser listed above. Zacks has no control over how
your email address is used by the advertiser or other third parties. Accordingly, Zacks disclaims all
responsibility and liability arising from the subsequent use of your email address that is made possible by
your submission of your email address above. You are receiving this email from Zacks Investment Research
because you chose to receive messages from Zacks’ partners on the Zacks web site(s). Please note that
Zacks does not produce or endorse this product, and assumes no responsibility for the use thereof.

Your privacy is important to us. Click here to see our Privacy Policy: https://www.zacks.com/privacy.php
If you do not wish to receive further email solicitations from Zacks on behalf of its partners, please click here
to unsubscribe.

Zacks Investment Research
10 S. Riverside Plaza, Suite 1600
Chicago, IL 60606